Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Is Elon Musk the most powerful civilian since Rasputin? The SpaceX owner’s political influence has soared but, like history’s other disruptors, it’s a test of where the power lies in a democracy ...

Cool wholesale inflation numbers provide only slight relief before Wednesday's release of December Consumer Price Index data.

stop loss @ 42.17 Details The technical summary data is suggesting a short of VKTX as it gets near 42.05, but the downside target is not available from the current data. This tells us to hold that ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Viking Therapeutics, Inc. (VKTX) closed at $42.53 in the latest trading session, marking a -0.84% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.55% for the ...

(Reuters) – Demand for global equity funds shrank in the week through Jan. 1, as higher U.S. Treasury yields led to caution and investors took profits during the year-end trading lull. Data from LSEG ...